Human T-cell lymphotropic virus type 1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis

Archives of Neurology

Volumn 54, Issue 7, 1997, Pages 896-900

  Douen, Andre G ^a   Elizabeth Pringle, C ^a   Guberman, Alan ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; PREDNISONE; STEROID;

AGED; ARTICLE; BRAIN DISEASE; CASE REPORT; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; MUSCLE BIOPSY; MYOSITIS; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SPASTIC PARESIS; WHITE MATTER;

EID: 1842296308     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550190084018     Document Type: Article

References (24)

1. Roman G, Spencer PS, Schoenberg BS. Tropical myeloneuropathies: the hidden endemias. Neurology. 1985;35:1158-1170.
2. Mora CA, Garruto RM, Brown P, et al. Seroprevalence of antibodies to HTLV-I in patients with chronic neurologic disorders other than tropical spastic paraparesis. Ann Neurol. 1988;23(suppl):S192-S195.
3. Vernant JC, Maurs L, Gessain A, et al. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: clinical and seroepidemiological study of 25 cases. Ann Neurol. 1987;21:123-130.
4. Osame M, Matsumoto M, Usuku K. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987;21:117-122.
5. Jacobson S. Human T lymphotropic virus, type-I myelopathy: an immunopathologically mediated chronic progressive disease of the central nervous system. Curr Opin Neurol. 1995;8:179-183.
6. Coyle PK, Bell WE, Davis LE, Hantey DF, McArthur JC. Viral infection. In: Mancall EL, ed. Continuum: The Neurologist and Infectious Disease. Minneapolis. Minn: American Academy of Neurology; 1993:43-73.
7. Osame M, McArthur JC. Neurologic manifestations of infection with human T-cell lymphotropic virus type-I. In: Asbury AK, McKhann GM, McDonald Wl, eds. Diseases of the Nervous System: Clinical Neurobiology. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1992:1331-1339.
8. Gabbai AA, Wiley CA, Oliveira ASB, et al. Skeletal muscle involvement in tropical spastic paraparesis/HTLV-I-associated myelopathy. Muscle Nerve. 1994;17:923-930.
9. Hokezu Y, Higuchi I, Yanai S, Nagai M, Nagamatsu K. A family case of HAM and HTLV-I carrier including two sisters presenting with myositis. Rinsho Shinkeigaku. 1994;34:563-568.
10. Sowa JM. Human T lymphotropic virus I, myelopathy, polymyositis, and synovitis: an expanding rheumatic spectrum. J Rheumatol. 1992;19:316-318.
11. Corbin DOC, Mora CA, Garriques S, Rodgers-Johnson P, Gibbs CJ Jr. Anterior horn cell degeneration in polymyositis associated with human T lymphotropic virus type-1 in patients from Barbados. Am J Trop Med Hyg. 1996;54:625-628.
12. Smadja D, Bellance R, Cabre PH, Arfi S, Vemant J-C. Clinical characteristics of HTLV-1 associated dermato-polymyosttis. Acta Neurol Scand. 1995;92:206-212.
13. Bhigjee AI, Bill PL, Wiley CA, et al. Peripheral nerve lesions in HTLV-I-associated myelopathy (HAM/TSP). Muscle Nerve. 1993;16:21-26.
14. Morgan OS, Rodgers-Johnson P, Mora CA, Char G. HTLV-I and polymyositis in Jamaica. Lancet. 1989;2:1184-1187.
15. Sherman MP, Rajnikant MA, Rodgers-Johnson PEB, et al. Identification of human T-cell leukemia/lymphoma virus type I antibodies, DNA, and protein in patients with polymyositis. Arthritis Rheum. 1995;38:690-698.
16. Leon-Monzon M, Illa l, Dalakas MC. Polymyositis in patients infected with human T-cell leukemia virus type-I: the role of the virus in the cause of the disease. Ann Neurol. 1994;36:643-649.
17. Power C, Weinshenker BG, Dekaban GA, Kaufmann JCE, Shandling M, Rice GPA. Pathological and molecular biological features of a myelopathy associated with HTLV-I infection. Can J Neurol Sci. 1991;18:352-355.
18. Higuchi I, Montemayor ES, Izumo S, Inose M, Osame M. Immunohistochemical characteristics of polymyositis in patients with HTLV-I-associated myelopathy and HTLV-I carriers. Muscle Nerve. 1993;16:472-476.
19. Ishii K, Yamato K, Iwahara Y, et al. Isolation of HTLV-I from muscle of a patient with polymyositis. Am J Med. 1991;90:267-269.
20. Lehky TJ, Fox CH, Koenig S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol. 1995;37:167-175.
21. Newton M, Cruickshank K, Miller D, et al. Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraplegia. Lancet. 1987;1:415-416.
22. Sheremata WA, Quencer R, Gatti E, Defreitas E, Harper M, Koprowski H, Magnetic resonance imaging (MRI) of tropical spastic paraplegia. Neurology. 1987;37(suppl):322. Abstract.
23. Cruickshank JK, Rudge P, Dalgleish AG, et al. Tropical spastic paraparesis and human T-cell lymphotropic virus type-1 in the United Kingdom. Brain. 1989;112:1057-1090.
24. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S. Isolation of HTLV-II from a patient with chronic progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol. 1993;33:392-396.